{"id":531667,"date":"2026-04-15T06:00:08","date_gmt":"2026-04-15T06:00:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/uk\/531667\/"},"modified":"2026-04-15T06:00:08","modified_gmt":"2026-04-15T06:00:08","slug":"vida-health-and-oura-to-deliver-continuous-personalized-metabolic-care","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/uk\/531667\/","title":{"rendered":"Vida Health and \u014cURA to Deliver Continuous, Personalized Metabolic Care"},"content":{"rendered":"<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">SAN FRANCISCO&#8211;(<a href=\"https:\/\/www.businesswire.com\" target=\"_blank\" rel=\"nofollow noopener\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow noopener\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vida.com%2F&amp;esheet=54498626&amp;newsitemid=20260414747061&amp;lan=en-US&amp;anchor=Vida+Health&amp;index=1&amp;md5=17376afac75af7365c454d50c22d84d0\" shape=\"rect\" target=\"_blank\">Vida Health<\/a>, a value-based, virtual cardiometabolic care provider that enables patients to manage metabolic instability, today announced it has teamed up with <a rel=\"nofollow noopener\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fouraring.com%2F&amp;esheet=54498626&amp;newsitemid=20260414747061&amp;lan=en-US&amp;anchor=%26%23332%3BURA&amp;index=2&amp;md5=7fd0fd88539e083787500325ec21c0d6\" shape=\"rect\" target=\"_blank\">\u014cURA<\/a>, maker of the world\u2019s leading smart ring, Oura Ring, to deliver a new model of continuous, personalized metabolic care. By integrating \u014cURA\u2019s real-time biometric data into Vida\u2019s clinical programs and existing datasets, the collaboration provides actionable insights that drive lasting behavior change, measurable health outcomes, and a data-driven approach for employers and health plans to improve workforce health and manage costs.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nWith the integration, Vida\u2019s care teams gain access to key physiological signals, including sleep, heart rate variability (HRV), and resting heart rate, combined with clinical and behavioral data. This comprehensive member health view enables earlier identification of potential risks and more informed care decisions between appointments, lab tests, and coaching sessions, improving member engagement and adherence.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\n\u201cProviders are often making decisions based on limited snapshots, such as on an office visit, lab result, or a patient\u2019s recollection,\u201d said Richard Frank, MD, Chief Medical Officer at Vida Health. \u201cWhat\u2019s been missing is a continuous view of how patients are actually doing day to day. By incorporating real-time insights from \u014cURA with our clinical expertise and whole-person care model, we can personalize support, intervene earlier, and help members make incremental changes that add up to meaningful results over time.\u201d<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nVida will leverage \u014cURA\u2019s biometric data and insights to refine and optimize care. This includes adjusting care plans based on changes in recovery or cardiovascular signals, personalizing coaching based on sleep and stress patterns, and identifying early warning signals before additional clinical intervention is required. The goal is to help members stay engaged in their care while enabling providers to intervene and adjust earlier and more effectively. For employers and health plans, this approach delivers an evidence-based pathway to improved employee outcomes and potential cost savings.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\n\u201cOne of the biggest gaps in healthcare is making continuous data clinically useful. Metabolic care extends beyond a single lab value or prescription and depends on how sleep, activity, stress and daily routines interact over time,\u201d said Ricky Bloomfield, MD, Chief Medical Officer at \u014cURA. \u201cThis joint effort gives care teams timely, contextual information to guide treatment decisions, outreach, and behavior-change support grounded in longitudinal trends rather than isolated readings, helping them better understand how members are doing between visits and respond more effectively.\u201d<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nThe partnership reflects a shift toward continuous, data-informed healthcare, where wearable technology extends care beyond episodic treatment. By combining personalized insights with evidence-based care, Vida and \u014cURA aim to improve metabolic health outcomes while also supporting higher engagement and reduced total cost of care.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nTo learn more, visit <a rel=\"nofollow noopener\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vida.com%2Fvida-oura-partnership%2F&amp;esheet=54498626&amp;newsitemid=20260414747061&amp;lan=en-US&amp;anchor=www.vida.com%2Fvida-oura-partnership&amp;index=3&amp;md5=63f2a71cb6ba16271b0fbc329260f475\" shape=\"rect\" target=\"_blank\">www.vida.com\/vida-oura-partnership<\/a>.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nAbout Vida Health<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nVida Health is a value-based, virtual cardiometabolic care provider that matches members to the right level of care based on their metabolic instability. Its medication guidance system prioritizes lower\u2011cost, high\u2011value therapeutic alternatives across obesity, diabetes, hypertension, hyperlipidemia, noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), obstructive sleep apnea (OSA), and chronic obstructive pulmonary disease (COPD). Vida serves members at all acuity levels, combining evidence-based prescribing with behavior change support and provider-led care. Vida\u2019s multidisciplinary team of obesity medicine-certified physicians, nurses, registered dietitians, expert coaches, and licensed therapists delivers a whole-person approach that improves outcomes while reducing avoidable healthcare costs. Vida serves members in all 50 states and Washington, D.C., offers services in both English and Spanish, and operates on a value-based pricing model that centers on measurable health outcomes. To learn more, visit <a rel=\"nofollow noopener\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vida.com%2F&amp;esheet=54498626&amp;newsitemid=20260414747061&amp;lan=en-US&amp;anchor=www.Vida.com&amp;index=4&amp;md5=41d528d4960f07309040bf469f1a25bd\" shape=\"rect\" target=\"_blank\">www.Vida.com<\/a>.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nAbout \u014cURA<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\n\u014cURA delivers personalized health data, insights, and daily guidance with Oura Ring, the leading smart ring that helps you live healthier, longer. Guided by a mission to shift healthcare from sick care to prevention, \u014cURA supports millions of members worldwide across sleep, activity, stress, readiness, women\u2019s health, and heart health. Scientifically validated against medical gold standards, the lightweight Oura Ring tracks 50+ health metrics continuously, empowering both individuals and thousands of research teams, healthcare providers, and organizations. With 1,000 ecosystem partners across wellness and medicine, \u014cURA is advancing the future of preventative health.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nFounded in Finland in 2013, \u014cURA has U.S. headquarters in San Francisco and E.U. headquarters in Oulu. \u014cURA was last valued at approximately $11B\u2014making it the world\u2019s most valuable standalone wearable company. Learn more at <a rel=\"nofollow noopener\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fouraring.com&amp;esheet=54498626&amp;newsitemid=20260414747061&amp;lan=en-US&amp;anchor=ouraring.com&amp;index=5&amp;md5=c9878b426f8a01589f045afc3a1adc79\" shape=\"rect\" target=\"_blank\">ouraring.com<\/a> or connect with \u014cURA on <a rel=\"nofollow noopener\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fouraring%2F%3Fhl%3Den&amp;esheet=54498626&amp;newsitemid=20260414747061&amp;lan=en-US&amp;anchor=Instagram&amp;index=6&amp;md5=c12c6f9c9342f2fb7a5667b92dae382e\" shape=\"rect\" target=\"_blank\">Instagram<\/a>, <a rel=\"nofollow noopener\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Foura%2F&amp;esheet=54498626&amp;newsitemid=20260414747061&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=7&amp;md5=30dc1406b8abae66d780b2768865e6a1\" shape=\"rect\" target=\"_blank\">LinkedIn<\/a>, and <a rel=\"nofollow noopener\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.tiktok.com%2F%40ouraring%3Flang%3Den&amp;esheet=54498626&amp;newsitemid=20260414747061&amp;lan=en-US&amp;anchor=TikTok&amp;index=8&amp;md5=07ac1b14569a36a30b421f624bcf8a10\" shape=\"rect\" target=\"_blank\">TikTok<\/a>.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nOura Ring is not a medical device and is not intended to diagnose, treat, cure, monitor, or prevent medical conditions or illnesses.<\/p>\n<p><script async src=\"\/\/www.instagram.com\/embed.js\"><\/script><script async src=\"\/\/www.tiktok.com\/embed.js\"><\/script><\/p>\n","protected":false},"excerpt":{"rendered":"SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Vida Health, a value-based, virtual cardiometabolic care provider that enables patients to manage metabolic instability, today&hellip;\n","protected":false},"author":2,"featured_media":531668,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[43],"tags":[102,2960,56,54,55],"class_list":{"0":"post-531667","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-health","9":"tag-healthcare","10":"tag-uk","11":"tag-united-kingdom","12":"tag-unitedkingdom"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/531667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/comments?post=531667"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/531667\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media\/531668"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media?parent=531667"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/categories?post=531667"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/tags?post=531667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}